Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    VLS.AX Gross Margin

    As of 2025-07-06, the Gross Margin of Vita Life Sciences Ltd (VLS.AX) is 59.4%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    VLS.AX Gross Margin - Historical Value
    DateValue
    2024-12-31 59.4%
    2023-12-31 58.1%
    2022-12-31 59.4%
    2021-12-31 61%
    2020-12-31 63%
    2019-12-31 65.7%
    2018-12-31 67.2%
    2017-12-31 67.4%
    2016-12-31 69.2%
    2015-12-31 70.4%
    VLS.AX Gross Margin - Peers Comparison
    TickerNameValue
    007370.KQJin Yang Pharmaceutical Co Ltd61.7%
    018620.KQWooGene B&G Co Ltd29.1%
    506260.BOAnuh Pharma Ltd24.8%
    524470.BOSyncom Formulations (India) Ltd3601.9%
    541400.BOZim Laboratories Ltd4893.6%
    AC8.AXAuscann Group Holdings Ltd100%
    ACR.AXAcrux Ltd51.1%
    AGH.AXAlthea Group Holdings Ltd60.7%
    ALBERTDAVD.NSAlbert David Ltd66.4%
    AVE.AXAvecho Biotechnology Ltd59.3%
    CGB.AXCann Global Ltd-13.9%
    DCL.VNCuu Long Pharmaceutical JSC15.7%
    ECS.AXECS Botanics Holdings Ltd36.3%
    IHL.AXIncannex Healthcare Ltd48.2%
    LGP.AXLittle Green Pharma Ltd66.3%
    MANGALAM.NSMangalam Drugs and Organics Ltd47.4%
    MXC.AXMGC Pharmaceuticals Ltd38%
    MYX.AXMayne Pharma Group Ltd57.1%
    NYR.AXNyrada Inc-348.2%
    OPC.VNOPC Pharmaceutical JSC41.6%
    PAA.AXNeurizon Therapeutics Ltd79.8%
    PBP.AXProbiotec Ltd30.1%
    RCE.AXRecce Pharmaceuticals Ltd-207.6%
    RNO.AXRhinomed Ltd74.8%
    THEMISMED.NSThemis Medicare Ltd67.5%
    VDP.VNVidipha Central Pharmaceutical JSC24.6%
    VENUSREM.NSVenus Remedies Ltd41.6%
    Tickers added to watchlist